A cooperative effect of KRAS mutation and the expression of c-MYC for invasion, as also observed in HCC44 cells in our model, and for immune modulation has been shown previously in animal studies for lung and pancreatic cancer [32,87]. Here, KRAS is linked to familial pancreatic carcinoma.